Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction-Reference-Cited by-同舟云学术

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction

Published:2003-06-27 Issue:1 Volume:56 Page:32-38
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Rengelshausen Jens,Göggelmann Christoph,Burhenne Jürgen,Riedel Klaus-Dieter,Ludwig Jochen,Weiss Johanna,Mikus Gerd,Walter-Sack Ingeborg,Haefeli Walter E.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.2003.01824.x/fullpdf

Reference30 articles.

1. Digoxin-macrolide drug interaction;Bizjak;Ann Pharmacother,1997

2. Clarithromycin-induced digoxin toxicity: a case report and a review of the literature;Xu;Conn Med,2001

3. Inactivation of digoxin by the gut flora: reversal by antibiotic therapy;Lindenbaum;N Engl J Med,1981

4. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein;Wakasugi;Clin Pharmacol Ther,1998

5. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1);Tanigawara;J Pharmacol Exp Ther,1992

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Interference of H9 Extract on Trastuzumab Pharmacokinetics in Their Combinations;International Journal of Molecular Sciences;2023-11-23

2. The Effect of BI 730357 (Retinoic Acid‐Related Orphan Receptor Gamma t Antagonist, Bevurogant) on the Pharmacokinetics of a Transporter Probe Cocktail, Including Digoxin, Furosemide, Metformin, and Rosuvastatin: An Open‐Label, Non‐randomized, 2‐Period Fixed‐Sequence Trial in Healthy Subjects;Clinical Pharmacology in Drug Development;2023-11-13

3. Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels;Molecules;2023-11-10

4. Machine Learning-Based Prediction of Digoxin Toxicity in Heart Failure: A Multicenter Retrospective Study;Biological and Pharmaceutical Bulletin;2023-04-01

5. Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach;Cardiovascular Drugs and Therapy;2023-03-04